Hepion Pharmaceuticals, Inc. cotiza a 0.12 USD y tiene una capitalización bursátil de $12M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific cla…
| Periodo | 2024-04 | 2023-11 | 2023-08 | 2023-05 |
|---|---|---|---|---|
| Real | $-81.23 | $-137.00 | $-184.00 | $-174.00 |
| Estimado | $-131.50 | $-156.00 | $-166.17 | $-180.00 |
| Sorpresa | +38.2% | +12.2% | -10.7% | +3.3% |
| Métrica | HEPA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -310.3% | -40.4% | -269.9% |
| ROA | -269.6% | -32.0% | -237.6% |
| Current Ratio | 10.25 | 2.84 | +7.41 |
| Debt / Equity | — | 0.28 | — |